Synaptic Pulse by Biogrip

Synaptic Pulse operates at the intersection of medical devices, robotics, hardware, and artificial intelligence. Its stated distinction is a non-invasive neuromuscular interface intended to decode motor intention before movement and translate it into real-time machine control. The company describes applications spanning dexterous teleoperation, robot learning, advanced prosthetics, rehabilitation, and human augmentation. This gives it a different emphasis from robotics companies focused mainly on robot hardware or AI software: its proposed contribution is an input layer connecting physiological signals to machines. Synaptic Pulse is an early-stage company founded in December 2021, with two reported funding rounds totaling $770,000 and an employee range of 1–10.

Synaptic Pulse’s documented trajectory begins with its founding in December 2021 and centers on developing a neuromuscular interface for human-machine control. Financing followed in two stages: a $100,000 pre-seed round on May 12, 2024 and a $670,000 seed round on Oct 1, 2024, bringing reported funding to $770,000. Techstars participated in both rounds, while Draper Associates and AJI Capital participated in the seed round; Draper Associates was the named lead. The company lists a Wireless Nerve-Machine Interface product and describes an approach combining high-density EMG, wireless sensing, and adaptive AI. Its recorded employee range is 1–10, so evidence of team expansion is limited. Overall, the profile indicates early-stage technology development, but does not establish the pace of technical validation or movement toward commercialization.